- Original investigation
- Open Access
Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfast
Cardiovascular Diabetology volume 10, Article number: 78 (2011)
Cinnamon has been shown to delay gastric emptying of a high-carbohydrate meal and reduce postprandial glycemia in healthy adults. However, it is dietary fat which is implicated in the etiology and is associated with obesity, type 2 diabetes and cardiovascular disease. We aimed to determine the effect of 3 g cinnamon (Cinnamomum zeylanicum) on GE, postprandial lipemic and glycemic responses, oxidative stress, arterial stiffness, as well as appetite sensations and subsequent food intake following a high-fat meal.
A single-blind randomized crossover study assessed nine healthy, young subjects. GE rate of a high-fat meal supplemented with 3 g cinnamon or placebo was determined using the 13C octanoic acid breath test. Breath, blood samples and subjective appetite ratings were collected in the fasted and during the 360 min postprandial period, followed by an ad libitum buffet meal. Gastric emptying and 1-day fatty acid intake relationships were also examined.
Cinnamon did not change gastric emptying parameters, postprandial triacylglycerol or glucose concentrations, oxidative stress, arterial function or appetite (p < 0.05). Strong relationships were evident (p < 0.05) between GE Thalf and 1-day palmitoleic acid (r = -0.78), eiconsenoic acid (r = -0.84) and total omega-3 intake (r = -0.72). The ingestion of 3 g cinnamon had no effect on GE, arterial stiffness and oxidative stress following a HF meal.
3 g cinnamon did not alter the postprandial response to a high-fat test meal. We find no evidence to support the use of 3 g cinnamon supplementation for the prevention or treatment of metabolic disease. Dietary fatty acid intake requires consideration in future gastrointestinal studies.
Free-living individuals are in the postprandial hyper-triglyceridemic state for the majority of a 24-h period . Dietary supplementations, such as traditional spices, that can limit lipemia and glycemia in the fed state, have important implications for prevention and management of metabolic diseases. Two decades ago, cinnamon (Cinnamomum zeylanicum) was proposed as a treatment for type 2 diabetes (T2D) when it was shown to display insulin-mimetic properties . Cinnamon has been proposed to act on numerous mechanisms relating to glucose and insulin function including improved cellular uptake of glucose through stimulation of insulin receptor kinase activity, increased insulin receptor phosphorylation and glycogen synthesis activity and reducing inflammation through antioxidant effects [3–7]. Chronic supplementation of 1 to 6 g cinnamon has been shown to have similar effects with regards to lowering of fasting glucose and lipid levels in diabetic patients . Acutely, a 5 g cinnamon bolus improved glycemic responses and insulin sensitivity when given 12 hours prior to, or with, an oral glucose tolerance test (OGTT) in healthy adults .
In addition to rate of glucose removal from circulation, plasma glucose concentration is also determined by the rate of glucose entering the circulation . Gastric emptying (GE) is an important determinant of rate of glucose appearance and blood glucose homeostasis in healthy and diabetic populations [11, 12]. Delayed GE could be part of the mechanism by which cinnamon improves glucose tolerance. When combined with a semi-solid, low-fat meal, 6 g cinnamon reduced postprandial glycemia and delayed GE in healthy subjects .
Vascular dysfunction has emerged as a critical step in the development and progression of CVD, specifically atherosclerosis . Vascular dysfunction refers to impairments in nitric oxide (NO)-mediated endothelium-dependent dilation, which is inversely related to an increase in vessel stiffness . These impairments may stem from decreased NO synthesis and/or release, in combination with exaggerated consumption by reactive oxygen species (ROS) . It has been postulated that postprandial lipemia may promote vascular dysfunction via an oxidative stress pathway [17–19].
The actions of dietary fatty acids on the gastrointestinal (GI) tract are still poorly understood. Acute ingestion of dietary fat can potently delay GE and reduce appetite ; these effects are partly mediated by the secretion of GI peptides including glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK) . Dietary fatty acid intake may be one factor that affects inter- and intra- subject variability in GE rates.
We aimed to determine if acute supplementation of 3 g cinnamon would reduce postprandial glycemic and lipemic responses to a high-fat (HF) meal through a delay in GE or an alternative mechanism. We also evaluated the effect of cinnamon ingestion on oxidative stress, vascular function, appetite sensations and subsequent food intake in healthy subjects. Additionally, we examined the relationship between previous day fatty acid intake and GE of the HF test meal.
Nine apparently healthy subjects (3 male, 6 female; age 26.2 ± 3 years; mass 66.5 ± 11.3 kg; BMI 22.4 ± 2.5 kg/m2; body fat 22.2 ± 6.5%) consented to participate in the study, which was approved by the Local Research Ethics Committee. Subjects had no history of GI-related complaints, CVD or diabetes and were not currently taking antioxidant or lipid-lowering medication. Subjects were non-smokers and were recreationally active (performing < 60 min of moderate to intense exercise per day, on every day of the week) determined using a 3 month exercise questionnaire. Fasting blood lipid, glucose and blood pressure (BP) levels were all within the normal limits. Subjects were required to rate at least 50% of the food items that would be presented in the buffet meal as 5 or higher in a food preference questionnaire for study inclusion. Two subjects were identified as restrained eaters (scoring > 12 on the eating restraint section (factor 1) of the Three-Factor Eating Questionnaire ).
Each subject completed two separate 1-day trials separated by 28 days: cinnamon and placebo (wheat flour) supplementation. Trials were conducted in a single-blind, placebo controlled randomized fashion and were identical apart from the content of the capsules. During the 3 d before the first trial, subjects recorded all of the food and drink that they consumed and repeated this diet before the second trial. Energy, macronutrient and fatty acid intake were calculated using CompEat Pro Nutritional Analysis software (Version 5.8; Nutrition Systems, Grantham, UK). Physical activity was also logged during this time period. Subjects were instructed to minimize their consumption of foods with naturally high 13C abundance on the day preceding each trial and were asked to refrain from alcohol consumption and vigorous exercise. Apart from these requirements, subjects ate and exercised ad libitum between the two testing periods.
Study day protocol
Subjects reported to the laboratory after a 12 h overnight fast. Following 15 min interval of supine rest, measurements of arterial stiffness (see measurements) and BP were obtained and a baseline blood sample was collected. Subjects returned to the seated position and after a 10 min interval, baseline breath samples were taken and visual analogue scale (VAS) questionnaires were completed (t = -15 and -10 min). Once baseline measurements were taken, subjects consumed the test meal within 15 min (see below). Upon completion of the meal (t = 0 min), sequential postprandial measurements of GE, appetite sensations, arterial stiffness, BP and plasma glucose and lipids responses were taken. Expired breath samples were collected at t = 0 min, every 5 min for the first half hour after meal consumption and thereafter in 15-min intervals from t = 30 until 360 min for the detection of 13CO2 (see measurements). VAS questionnaires were administered after consumption of breakfast (t = 0 min) and every 30 min until t = 360 min. Arterial stiffness, BP measurements and blood samples were collected hourly from t = 60 to t = 270 min (t = 240 min for blood samples). At the end of postprandial assessments (t = 360 min), subjects were presented with an assortment of cold lunch-type buffet foods. The meal comprised of six slices of wholegrain bread (235 g), six slices of white bread (235 g), 115 g sliced ham, 115 g sliced chicken, 100 g grated cheddar cheese, 60 g lettuce, 125 g cherry tomatoes, 80 g sliced cucumber, 90 g sweet corn, 100 g coleslaw, 30 g butter, 30 g mayonnaise, 30 g relish, 415 g strawberry yoghurt, 6 biscuits (75 g), 120 g chocolate Swiss roll, 60 g crisps and 300 ml water. The total energy content of the buffet meal was 16504 kJ. The selection presented was in excess of anticipated consumption. Subjects were given 30 min (i.e. t = 360 - 390 min) to eat ad libitum until 'comfortably full'. After ingestion of the buffet meal, subjects completed another VAS questionnaire and were then free to leave the laboratory. Additional VAS questionnaires were administered after consumption of the test meal and buffet meal (t = 0 and 390 min) to evaluate meal palatability as well as sensations of nausea and well-being. They recorded their subsequent food intake for the remainder of the test day.
The test meal consisted of three pancakes (36 g flour, 44 g egg, 70 g whole milk, 30 g sunflower oil) served with 20 g chocolate spread and 300 ml of water. The test meal was enriched with 150 μl 13C octanoic acid (Cambridge Isotope Laboratories, Andover, MA, USA), which was solubilized in the egg yolk prior to cooking. After homogenizing the yolk, it was mixed with the other ingredients to ensure uniform distribution of the label throughout the pancake batch. The test meal provided 2646 kJ of energy and consisted of 42 g carbohydrate, 46 g fat and 13 g protein. Subjects were instructed to ingest 8 gelatin capsules (four directly before and after meal) totaling 3 g Cinnamon powdered spice (Cinnamomum zeylanicum; Schwartz, UK) or a wheat flour placebo (Odlums, Ireland).
Gastric emptying was determined using the 13C octanoic acid breath test [23, 24]. Breath samples were collected into 10 ml tubes (Exetainers; Labco, Bucks, UK). The analysis of the 13CO2/12CO2 enrichment in breath samples was performed using an ABCA (Europa Scientific, Crewe, UK) isotope ratio mass spectrometer. GE parameters, gastric half emptying time (Thalf), lag phase (Tlag), latency time (Tlat) and ascension time (Tasc) were calculated using previously described methods [23, 25]. Cumulative excretion of 13CO2 (as a percent of ingested dose) was also calculated.
Arterial stiffness was measured using the PulseTrace PCA 2 device (Micro Medical, Kent, UK). The device measures the digital volume pulse (DVP) through the use of a photoplethysmographic transducer placed on the index finger of the right hand, transmitting infra-red light at 940 nm. The device permits the calculation of the stiffness index (SI; m/s) and the reflection index (RI; %) [26, 27]. Heart rate (HR) in beats/min (bpm) was also measured by transmission of the DVP.
Systemic arterial blood pressure (BP) was measured at the brachial artery using an Omran M5-I fully automatic BP monitor (Surrey, UK). Measurements were taken in triplicate directly after arterial stiffness measurements in the supine position and an average of these readings was recorded.
Blood samples were collected into K-EDTA and NaF tubes and placed on ice. Serum separating clot activator tubes were allowed to clot at room temperature. All samples were separated within 30 min of collection and stored at -70°C until analysis. Plasma glucose was determined by an immobilized enzyme membrane method in conjunction with a Clark electrode on a YSI 2300 analyzer (Yellow Springs, USA). Total cholesterol, TAGs and HDL were measured by enzyme assay kits, using an automated analyzer (Aeroset ™, Abbott Labs, USA ). LDL cholesterol was calculated using the Friedewald equation . All samples for each subject were analyzed in a single analyzer run. CVs were < 7.7% for glucose and < 10.0% for all blood lipids.
Serum lipid hydroperoxides
Serum lipid hydroperoxides (LOOHs) (as measures of lipid peroxidation) were incubated with FOX-1 assay and quantified using a Shimadzu UV-VIS 1240 Spectrophotometer, (Mason Technology, Belfast, Northern Ireland . CV was < 16% for LOOH.
Appetite sensations and subsequent energy intake
Sensations of hunger, desire to eat, fullness, thirst, tiredness and coldness were assessed using a VAS questionnaire . Although it was important to examine general well being, the latter sensations were primarily included so that subjects were unaware that our primary outcome measures were sensations of appetite. Each VAS assessed a sensation on a 150 mm horizontal line anchored at the beginning and end by opposing statements.
The quantity of food consumed in the buffet meal was recorded to the nearest 0.1 g and the total energy (kJ) and macronutrient intakes (% of energy) were subsequently calculated. Time taken to complete the buffet meal completion (in min) was also recorded.
Data were checked for normal distribution before statistical analysis was preformed. Appetite sensation data was transformed by natural log. Fasting measurements of arterial stiffness, blood pressure and plasma lipid and glucose concentrations were calculated as the mean of the values collected at baseline (~t = -30 to -20 min). Baseline GE and appetite sensation scores were calculated as the mean of values collected at t = -15 and -10 min. Blood biomarkers, appetite sensations and arterial stiffness data were analyzed using a two-way (time × supplement) repeated-measures ANOVA. Incremental area under the glycemic curve (IAUC) was calculated using the trapezoidal rule by subtracting baseline values from measured plasma glucose concentrations. Relationships between variables were compared using Pearson correlations. Paired-sample t tests were used to compare GE parameters, habitual diet, physical activity intensity and duration as well as food intake at the buffet meal (quantity, energy consumed and macronutrient distribution). Statistical significance was established at the p < 0.05 level and the mean values ± SD are reported. All statistical analyses were carried out using SPSS-version 16.0 (SPSS, Inc., Chicago, IL, USA). Power calculation was conducted for gastric emptying Thalf the primary endpoint evaluation. A sample size of 9 subjects was necessary to detect a 15.8% change in GE rate  in a two-sided paired Students' t-test with alpha set at 5% and a power of 80%. Trial registration number: at http://www.clinicaltrial.gov: NCT01350284.
Test days were well tolerated by all subjects. Subjects successfully repeated their food and physical activity diaries as indicated by no significant differences in energy or macronutrient intake (p > 0.05) and in total and exercise intensities respectively (p > 0.05) for 3 days prior to each treatment. Usual dietary intake was consistent with guidelines for healthy living (51% of energy from carbohydrate, 31% fat, and 18% protein).
No significant effect of cinnamon supplementation was observed on gastric emptying parameters (Table 1).
There were no mean differences between or within the groups for SI (time × supplement interaction, p > 0.05) (Table 2). However, a main effect for time was observed whereby SI decreased postprandially in both supplements (pooled placebo and drug data, p < 0.05). There were no reported differences either between or within supplements for RI over time following the ingestion of the test meal (time × supplement interaction, p > 0.05) (Table 2).
Blood pressure and heart rate
There were no differences either between or within the groups for both systolic and diastolic BP over time following the ingestion of the test meal (time × supplement interaction, p > 0.05). There were no mean differences between or within the groups for HR (time × supplement interaction, p > 0.05). However, a main effect for time was observed whereby HR decreased over time across both trials (60 ± 10 bpm at baseline vs. 52 ± 9 bpm at 300 min post meal in placebo trial; 61 ± 12 bpm at baseline vs. 51 ± 9 bpm at 300 min post meal in cinnamon trial; pooled placebo and drug data, p < 0.05).
Baseline plasma glucose concentrations tended to be higher after cinnamon supplementation compared to placebo (p > 0.05; n = 8 for all blood derived measurements). Plasma glucose concentrations changed across time in response to both supplementations (p < 0.0001) (Figure 1). There was no significant interaction between time and supplement (p > 0.05). Three hours after meal ingestion all plasma glucose concentrations were similar to baseline concentrations, regardless of supplement. IAUC following placebo (-22.2 ± 87.6 mmol/l/min) was similar to that following cinnamon ingestion (-14.2 ± 29.1 mmol/l/min, p = 0.819).
Baseline plasma TAG, total cholesterol, HDL and LDL concentrations did not differ significantly between trials (Table 3). There were no changes in TAG between trials (time × treatment interaction, p > 0.05) but there was a main effect for time (pooled placebo and cinnamon data, p < 0.05). There were no changes in plasma total cholesterol, HDL, or LDL levels either within or between the trials (time × supplement interaction; p > 0.05).
Serum lipid hydroperoxides
There was a main effect for time for LOOHs with levels increasing over time throughout the course of the trials (pooled placebo and cinnamon data, p < 0.05) but there were no changes in mean LOOHs between or within the groups (time × supplement interaction, p > 0.05) (Figure 2).
Appetite sensations and subsequent energy intake
The variables thirst, tiredness and coldness did not vary significantly with supplementation or over time (data not shown). Baseline appetite sensation VAS scores did not differ significantly between conditions. Changes to appetite sensation scores were evident over time after ingestion of test meals (p < 0.05). No significant effect of treatment was observed on sensations of hunger (Figure 3), desire to eat and fullness (data not shown). No differences between sensations of palatability, pleasantness, nausea and stomach pain recorded when treatments were compared after the test breakfast (t = 0 min) and buffet-style lunch meal (t = 390 min). No significant effect of treatment was observed for quantity of food consumed, energy intake, percentage of energy provided by carbohydrate, fat or protein and time taken to consume the buffet meal (Table 1).
Relationship between variables
Significant positive correlations were observed between TAG levels and LOOHs (r = 0.52, p < 0.0001) and SI and LOOH (r = 0.24, p < 0.05). GE Thalf was inversely related to energy intake in the buffet meal after cinnamon ingestion (r = -0.67, p < 0.05) but not in the placebo trial (r = -0.62, p > 0.05).
Relationship between gastric emptying and 3-day background fatty acid intake
No significant differences were observed between 1-day background fatty acid intake before cinnamon and placebo trials. 1-day intake of palmitoleic acid (C16:1, r = -0.78, p < 0.05), eiconsenoic acid (C20:1, r = -0.84, p < 0.01) and total n-3 intake respectively (r = -0.72, p < 0.05) were inversely related to GE Thalf of the placebo-supplemented HF meal (Table 4). 1-day intake of C16:1, C20:1 and total n-3 fatty acids accounted for 61, 71 and 51% of the variance in GE Thalf respectively. No significant relationships between GE Thalf after cinnamon ingestion and 1-day of palmitoleic acid, eiconsenoic acid or total n-3 intake were observed (p > 0.05).
The current study tested the hypothesis that supplementing a single HF breakfast with 3 g of cinnamon would delay GE of a high-fat solid meal utilizing the 13C octanoic acid breath test, and consequently reduce postprandial blood glucose and lipid concentrations.
Gastric Emptying, Metabolic Variables and Appetite
We were unable to induce significant changes in GE using 3 g of cinnamon. The test meal (65% of energy from fat) was mainly from sunflower oil, which contains approximately 70% linoleic acid (C18:2n-6, a PUFA ). Long-chain fatty acids have a potent inhibitory effect on GE rate [20, 32] and have also been shown to increase CCK and GLP-1 concentrations . We propose that cinnamon does not delay GE over and above the effects of the fat content of the meal. Furthermore, we found similar postprandial glycemic and lipemic responses under both conditions. However, it should be noted that we were unable to measure a hyperglycemic or hyperlipidemic state. Studies which employed the largest doses of cinnamon relative to carbohydrate in the test meal (carbohydrate/cinnamon ratio of 15 or lower [9, 13]) appear to have had the most potent effects on reducing postprandial glycemia . In spite of the current high ratio of 14, we did not achieve a significant blood glucose-lowering effect. This is possibly due to glucose absorption from the small intestine being affected by the fat content of a meal .
Recent data indicates that the addition of 3 g cinnamon to a low-fat rice pudding test meal had no significant effect on GE rate or postprandial glycemia in healthy individuals . However, cinnamon did significantly lower serum insulin levels and increase GLP-1 concentrations, a GI peptide which has been shown to increase glucose-dependent secretion of insulin, delay GE and reduce glucose absorption and postprandial glycemia [36, 37]. When added to the same test meal, 6 g cinnamon significantly delayed GE and reduced postprandial glycemia but the decrease in blood glucose concentration was more apparent than the delay in GE rate suggesting that GE cannot be the sole mechanism explaining lower blood glucose responses following cinnamon ingestion . Agreeing with the findings of others [13, 33, 34], we found that cinnamon did not influence appetite sensations or subsequent food intake, probably as a result of similar GE rates between conditions . Together with data presented in the current study, cinnamon is unlikely to be relevant in affecting the postprandial response to HF meals.
Diet and fatty acid intake
Assessment of previous day dietary intake indicated that a higher intake of C16:1, C20:1 and total n-3 was associated with a shorter GE Thalf of the HF meal supplemented with the wheat flour placebo. To our knowledge, this is the first observation of specific dietary fatty acids from preceding diet affecting GI transit in humans. A single meal, supplemented with n-3 PUFAs, was less capable of triggering GLP-1 and CCK compared to other fats, resulting in a more rapid GE of a HF breakfast  while others showed that n-3 PUFA fish oil reduced CCK release and gallbladder contraction without affecting GE . Both GLP-1 and CCK are putative mediators of the ileal brake, a feedback mechanism responsible for delaying transit and facilitating digestion, in response to lipids in the distal GI tract . Our current findings extend these observations to illustrate that even short-term intake of n-3 fatty acids is associated with faster GE rates, in a population who were not eating a HF diet. This means that mechanisms apart from acute release of GLP-1 and CCK, must mediate the effects of specific fatty acids on GI transit. Recently, a 3-day HF yoghurt supplementation, rich in C18:2n-6 accelerated the GE rate of a test meal rich in the same fatty acid . It is interesting to note that background intake of C18:2n-6, which was high in the test meal, did not show a strong association with GE of the meal. Our observations suggest that GE Thalf of a HF meal is not just specifically affected by a background intake of that specific fatty acid and that the process of adaptation to a HF diet may involve mechanisms other than desensitization to a specific fatty acid. It is likely that different adaptations are continuously taking place in the gut, in response to the balance of fatty acids in the diet. It is tempting to speculate about the potential mechanisms for fat sensing and adaptation following the recently sequenced GPR120 protein, expressed on intestinal cells, and demonstrated to be differentially sensitive to different fatty acids .
Vascular Function and antioxidant capacity
One of the principle findings of this study was that no changes were observed in relation to the measures of vascular function. Interestingly, there was a main effect for time indicating a decrease in SI which at face value appears paradoxical given the transient impairment in vessel function following the ingestion of a HF meal [44, 45]. This apparent contradiction might be explained by the fact the test meal we used may not have been of sufficient energy and, in particular, fat content to evoke a change in vessel function. In most of the related literature the postprandial TAG concentration associated with vascular dysfunction (~2.0 mmol/l; [17, 18, 44]) is double than that presently observed. Moreover, the HF meal in the current study contained 297 - 1742 kJ less energy (and 14 - 34 g less fat) than other similarly designed investigations [17, 45–47]. Such discrepancies in meal composition further highlight the need for a standardized, physiologically relevant HF meal  to be used in future corresponding studies, similar to the OGTT.
Due to its polyphenolic nature, cinnamon is thought to exhibit antioxidant properties [3, 49] which may be anti-atherogenic. It is proposed that the impairments in blood vessel function following the ingestion of HF loads are perpetrated via an oxidative stress mechanism that can increase the unwanted consumption of NO and favor the formation of further ROS, such as peroxynitrite (ONOO-) [17–19, 28, 44]. In the present study cinnamon ingestion had no apparent effect on indices of oxidative stress as a main effect for time was observed for LOOHs.
It has been documented that even high-normal fasting glucose levels can aggravate arterial stiffness  but when cinnamon was added to rats fed a high-fat high-fructose diet hepatic glycogen, hepatic insulin receptors and glut4 transporter in muscle tissue all increased . Despite no reported change in arterial stiffness using our physiologically relevant high-fat meal, the possibility therefore exists that cinnamon could modulate stiffness by affecting (hepatic) glycemic control and thus this relationship merits further scrutiny.
Emerging research postulates the existence of a diurnal variation in endothelial function . Fluctuations in the competitive balance between intrinsic local vasodilator function and sympathetic nervous system (SNS) α-adrenoreceptor-mediated vasoconstriction have recently been proposed as one potential mechanism to explain such findings . Given the conceptual relationship between endothelial function and arterial stiffness, and the observed main effect for a decrease in HR (as an indirect measure of SNS activity), it is tempting to speculate that this explanation may in some way account for the SI data in the current investigation. Conversely, this was tempered by the fact that no changes in RI were recorded.
This study may have been underpowered and therefore a small effect below the detection threshold of the study cannot be ruled out. Three grams of cinnamon was used as because it was shown to have a similar chronic effect on fasting serum glucose and lipid profiles as 6 g . However, recent evidence suggests a dose-dependent relationship for cinnamon consumed and the delay in GE [13, 35].
We found no evidence for delayed GE rate or reduced indices of oxidative stress in response to a HF meal supplemented with 3 g cinnamon compared to placebo. Cinnamon did not change postprandial glycemic and lipemic responses, arterial stiffness or appetite. Given the association between 1-day fatty acid intake and GE Thalf, we suggest that controlling for background fatty acid composition requires consideration in future gastrointestinal studies.
type 2 diabetes
oral glucose tolerance test
reactive oxygen species
visual analogue scale
- T half :
gastric half emptying time
- T lag :
- T lat :
- T asc :
digital volume pulse
sympathetic nervous system
Williams CM: Postprandial lipid metabolism: effects of dietary fatty acids. Proc Nutr Soc. 1997, 56: 679-92. 10.1079/PNS19970068.
Khan A, Bryden NA, Polansky MM, Anderson RA: Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res. 1990, 24: 183-8. 10.1007/BF02917206.
Kirkham S, Akilen R, Sharma S, Tsiami A: The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab. 2009, 11: 1100-13. 10.1111/j.1463-1326.2009.01094.x.
Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y: Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res. 2004, 36: 119-25.
Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, Anderson RA, Graves DJ: Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998, 50: 177-82. 10.1159/000023270.
Jarvill-Taylor KJ, Anderson RA, Graves DJ: A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr. 2001, 20: 327-36.
Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ: Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004, 52: 65-70. 10.1021/jf034916b.
Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA: Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003, 26: 3215-8. 10.2337/diacare.26.12.3215.
Solomon TP, Blannin AK: Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab. 2007, 9: 895-901. 10.1111/j.1463-1326.2006.00694.x.
Schenk S, Davidson CJ, Zderic TW, Byerley LO, Coyle EF: Different glycemic indexes of breakfast cereals are not due to glucose entry into blood but to glucose removal by tissue. Am J Clin Nutr. 2003, 78: 742-8.
Horowitz M, Edelbroek MA, Wishart JM, Straathof JW: Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia. 1993, 36: 857-62. 10.1007/BF00400362.
Rayner CK, Samson M, Jones KL, Horowitz M: Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001, 24: 371-81. 10.2337/diacare.24.2.371.
Hlebowicz J, Darwiche G, Björgell O, Almér LO: Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr. 2007, 85: 1552-6.
Quyyumi AA: Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med. 1998, 105: S32-9.
Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH: Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J. 2006, 27: 302-9.
Cersosimo E, DeFronzo RA: Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006, 22: 423-36. 10.1002/dmrr.634.
Bae JH, Bassenge E, Kim KB, Kim YN, Kim KS, Lee HJ, Moon KC, Lee MS, Park KY, Schwemmer M: Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 2001, 155: 517-23. 10.1016/S0021-9150(00)00601-8.
Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycaemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 2002, 106: 1211-8. 10.1161/01.CIR.0000027569.76671.A8.
van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, Castro Cabezas M: Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003, 44: 576-83. 10.1194/jlr.M200419-JLR200.
Cecil JE, Francis J, Read NW: Comparison of the effects of a high-fat and high-carbohydrate soup delivered orally and intragastrically on gastric emptying, appetite, and eating behaviour. Physiol Behav. 1999, 67: 299-306. 10.1016/S0031-9384(99)00069-4.
Feltrin KL, Little TJ, Meyer JH, Horowitz M, Smout AJ, Wishart J, Pilichiewicz AN, Rades T, Chapman IM, Feinle-Bisset C: Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol. 2004, 287: R524-33. 10.1152/ajpregu.00039.2004.
Stunkard AJ, Messick S: The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985, 29: 71-83. 10.1016/0022-3999(85)90010-8.
Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G: Measurement of gastric emptying rate of solids by means of a carbon-labelled octanoic acid breath test. Gastroenterology. 1993, 104: 1640-7.
Clegg M, Shafat A: Gastric emptying and oroceacal transit time of meals containing lactulose or inulin in men. Br J Nutr. 2010, 104: 554-9. 10.1017/S0007114510000905.
Schommartz B, Ziegler D, Schadewaldt P: Significance of diagnostic parameters in [13C]octanoic acid gastric emptying breath tests. Isotopes Environ Health Stud. 1998, 34: 135-43.
Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, Ritter JM, Anggård EE: Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol. 1999, 34: 2007-14. 10.1016/S0735-1097(99)00441-6.
Millasseau SC, Guigui FG, Kelly RP, Ritter JM, Chowienczyk PJ: Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond). 2002, 103: 371-77.
McClean CM, Mc Laughlin J, Burke G, Murphy MH, Trinick T, Duly E, Davison GW: The effect of acute aerobic exercise on pulse wave velocity and oxidative stress following postprandial hypertriglyceridemia in healthy men. Eur J Appl Physiol. 2007, 100: 225-34. 10.1007/s00421-007-0422-y.
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
Flint A, Raben A, Blundell JE, Astrup A: Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000, 24: 38-48. 10.1038/sj.ijo.0801083.
Sobrino E, Tarquis AM, Cruz Díaz M: Modeling the oleic acid content in sunflower oil. Agron J. 2003, 95: 329-334. 10.2134/agronj2003.0329.
Hunt J, Knox M: An effect of chain length of fatty acids in inhibition of gastric emptying. J Physiol. 1968, 194: 327-36.
Mettler S, Schwarzb I, Colombania PC: Additive postprandial blood glucose-attenuating and satiety-enhancing effect of cinnamon and acetic acid. Nutr Res. 2009, 29: 723-27. 10.1016/j.nutres.2009.10.002.
Normand S, Khalfallah Y, Louche-Pelissier C, Pachiaudi C, Antoine JM, Blanc S, Desage M, Riou JP, Laville M: Influence of dietary fat on postprandial glucose metabolism (exogenous and endogenous) using intrinsically 13C-enriched durum wheat. Br J Nutr. 2001, 86: 3-11. 10.1079/BJN2001359.
Hlebowicz J, Hlebowicz A, Lindstedt S, Björgell O, Höglund P, Holst JJ, Darwiche G, Almér LO: Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulintropic polypeptide, glucagon-like peptide-1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr. 2009, 89: 1-7.
Deane AM, Nguyen NQ, Stevens JE, Fraser RJ, Holloway RH, Besanko LK, Burgstad C, Jones KL, Chapman MJ, Rayner CK, Horowitz M: Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycaemia. J Clin Endocrinol Metab. 2010, 95: 215-21. 10.1210/jc.2009-1503.
Näslund E, Bogefors J, Skogar S: GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol. 1999, 277: R910-6.
Delzenne N, Blundell J, Brouns F: Gastrointestinal targets of appetite regulation in humans. Obes Rev. 2010, 11: 234-50. 10.1111/j.1467-789X.2009.00707.x.
Robertson MD, Jackson KG, Fielding BA, Morgan LM, Williams CM, Frayn KN: Acute ingestion of a meal rich in n-3 polyunsaturated fatty acids results in rapid gastric emptying in humans. Am J Clin Nutr. 2002, 76: 232-8.
Riber C, Hojgaard L, Madsen JL, Rehfeld JF, Olsen O: Gallbladder emptying and cholecystokinin response to fish oil and trioleate ingestion. Digestion. 1996, 57: 161-4. 10.1159/000201330.
Dobson CL, Davis SS, Chauhan S: Does the site of intestinal delivery of oleic acid alter the ileal brake response?. Int J Pharm. 2000, 195: 63-70. 10.1016/S0378-5173(99)00344-0.
Clegg ME, McKenna P, McClean C, Davison GW, Trinick T, Duly E, Shafat A: Gastrointestinal transit, post-prandial lipaemia and satiety following 3 days high-fat diet in men. Eur J Clin Nutr. 2011, 65: 240-6. 10.1038/ejcn.2010.235.
Moore K, Zhang Q, Murgolo N, Hosted T, Duffy R: Cloning, expression, and pharmacological characterization of the GPR120 free fatty acid receptor from cynomolgus monkey: comparison with human GPR120 splice variants. Comp Biochem Physiol B Biochem Mol Biol. 2009, 154: 419-26. 10.1016/j.cbpb.2009.08.005.
Tsai WC, Li YH, Lin CC, Chao TH, Chen JH: Effects of oxidative stress on endothelial function after a high-fat meal. Clin Sci (Lond). 2004, 106: 315-19. 10.1042/CS20030227.
Clegg M, McClean C, Davison GW: Exercise and postprandial lipaemia: effects on peripheral vascular function, oxidative stress and gastrointestinal transit. Lipids Health Dis. 2007, 6: 30-5. 10.1186/1476-511X-6-30.
Gaenzer H, Sturm W, Neumayr G: Pronounced postprandial lipaemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res. 2001, 52: 509-16. 10.1016/S0008-6363(01)00427-8.
Gill JM, Al-Mamari A, Ferrell WR: Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol. 2004, 44: 2375-82. 10.1016/j.jacc.2004.09.035.
Ridker PM: Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?. Clin Chem. 2008, 54: 11-3. 10.1373/clinchem.2008.105601.
Amin KA, El-Twab TMA: Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon. Int J Clin Exp Med. 2009, 2: 254-65.
Shin JY, Lee HR, Lee DC: Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol. 2011, 10: 30-10.1186/1475-2840-10-30.
Couturier K, Qin B, Batandier C: Cinnamon increases liver glycogen in an animal model of insulin resistance. Metabolism.
Otto ME, Svatikova A, Barretto RB: Early morning attenuation of endothelial function in healthy humans. Circulation. 2004, 109: 2507-10. 10.1161/01.CIR.0000128207.26863.C4.
Jones H, Green DJ, George KP, Black MA, Atkinson G: Evidence for a greater elevation in vascular shear stress after morning exercise. Med Sci Sports Exerc. 2009, 41: 1188-93. 10.1249/MSS.0b013e318195109c.
We thank K Horner, J Joyce and W McCormack for their assistance on experimental test days. This research was supported by the Irish Research Council for Science, Engineering and Technology.
The authors declare that they have no competing interests.
The author's responsibilities were as follows - OM and AS contributed to all aspects of this study. CM, PM, GWD, TT and ED contributed to acquisition of data, or analysis and interpretation of data. All authors read, revised and approved the final manuscript.
About this article
Cite this article
Markey, O., McClean, C.M., Medlow, P. et al. Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfast. Cardiovasc Diabetol 10, 78 (2011) doi:10.1186/1475-2840-10-78
- antioxidant capacity
- type 2 diabetes
- fatty acids
- omega-3 fatty acids